Company intelligence / Profile preview

Novopro Labs

Shanghai, Shanghai, China

Ownership: Private
Employees: ~150
Development stage: Other

Overview

NovoPro Bioscience is a contract research organization (CRO) specializing in protein, peptide, and antibody services for the global life sciences community. The company provides a comprehensive suite of solutions including custom peptide synthesis, recombinant protein expression in various systems such as E. coli, yeast, insect, and mammalian cells, and polyclonal/monoclonal antibody development. NovoPro also offers specialized services such as gene synthesis and stable cell line construction to support drug discovery and basic research. With a focus on high-quality production and technical support, the company serves academic institutions, pharmaceutical companies, and biotechnology firms worldwide.

Modalities: PeptidesProteinRecombinant proteinMonoclonal antibodyAntibody
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Novopro Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novopro Labs.

Explore the full profile